Text Size
11 studies found for:    Open Studies | "Pneumococcal Infections"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pneumococcal Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infections
Intervention: Biological: Prevnar 13 (PVC13)
2 Unknown † Early Versus Delayed Pneumococcal Vaccination in HIV
Condition: Pneumococcal Infections
Interventions: Biological: Pneumovax or Pneumo23;   Biological: Prevnar
3 Not yet recruiting Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: Pneumococcal Infections;   HIV Infections
Interventions: Biological: PPV-23 Vaccine;   Biological: PCV-13 Vaccine;   Biological: Placebo Vaccine
4 Unknown † PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
Conditions: Middle Ear Effusion;   Tympanic Membrane Perforation;   Acute Otitis Media;   Pneumococcal Infections
Intervention: Biological: 23 valent pneumococcal polysaccharide vaccine
5 Unknown † PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers
Conditions: Middle Ear Effusion;   Tympanic Membrane Perforation;   Acute Otitis Media;   Pneumococcal Infections
Intervention: Biological: 23vPPV, dTpa (Pneumovax, Boostrix)
6 Not yet recruiting Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso
Condition: Pneumococcal Infections
Intervention: Biological: Prevnar13 (manufactured by Pfizer)
7 Not yet recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection
Conditions: Invasive Diseases;   Pneumonia and Acute Otitis Media (AOM) Caused by Streptococcus Pneumoniae
Intervention: Biological: Synflorix™
8 Not yet recruiting Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) in the Young and Elderly
Condition: Pneumococcal Infection
Intervention: Biological: PNEUMOVAX
9 Recruiting Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Conditions: Seizures;   Pneumococcal Meningitis
Interventions: Drug: Phenytoin;   Drug: placebo
10 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
11 Not yet recruiting Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
Condition: Community-acquired Pneumonia
Intervention: Procedure: Observation
To Top

† Indicates status has not been verified in more than two years